Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **interatrial septum** is a thin fibromuscular wall that separates the right and left atria of the heart. Its primary function in postnatal life is to prevent mixing of blood between these two chambers. During fetal development, it contains an opening called the foramen ovale that allows blood to bypass nonfunctional fetal lungs by flowing from the right to left atrium; this typically closes after birth. Abnormalities in its formation can result in conditions such as patent foramen ovale or other types of atrial septal defects, which may predispose individuals to cardiovascular complications including arrhythmias and increased risk of stroke. The interatrial septum is an anatomical structure rather than a molecular target like receptors or enzymes; therefore, it is not considered a therapeutic target itself but may be involved indirectly in procedures such as catheter ablation for arrhythmias[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interatrial septum.